» Articles » PMID: 17916907

Involvement of Matrix Metalloproteinase-9 in Stromal Cell-derived Factor-1/CXCR4 Pathway of Lung Cancer Metastasis

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2007 Oct 6
PMID 17916907
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Lung caner cells have a striking tendency to metastasize to bone. The chemokine stromal cell-derived factor-1 (SDF-1) is constitutively secreted by osteoblasts and bone marrow stromal cells and plays a key role for homing of hematopoietic cells to the bone marrow. Reverse transcriptase-polymerase chain reaction and flow cytometry studies demonstrated SDF-1 receptor (CXCR4) messenger RNA (mRNA) and surface expression of CXCR4 in lung cancer cell lines, especially higher in those with high invasiveness (A549) as compared with lower level in H928 cells and H1299 cells. SDF-1, osteoblast-conditioned medium (OBCM) and stromal cell-conditioned medium all induced the invasiveness of lung cancer cells. Matrix metalloproteinase (MMP)-9 small interfering RNA inhibited the SDF-1alpha- or OBCM-induced MMP-9 expression and thereby significantly inhibited the SDF-1alpha- or OBCM-induced cell invasion. Furthermore, mitogen-activated protein kinase kinase inhibitor PD98059 suppressed SDF-1alpha-induced MMP-9 mRNA expression. Transient transfection with dominant-negative extracellular signal-regulated kinase (ERK) mutant also showed that the ERK-signaling pathway was involved in SDF-1alpha-induced MMP-9 expression. Moreover, nuclear factor-kappaB (NF-kappaB) decoy oligodeoxynucleotide suppressed the MMP-9 promoter activity enhanced by SDF-1alpha. Both mitogen-activated protein kinase kinase inhibitor and ERK mutant also antagonized SDF-1alpha-induced NF-kappaB-driven luciferase promoter activity. Taken together, our results indicated that bone marrow-derived-SDF-1alpha enhances the invasiveness of lung cancer cells by increasing MMP-9 expression through the CXCR4/ERK/NF-kappaB signal transduction pathway.

Citing Articles

Could Plasma CXCL12 Predict Ventricular Dysfunction in Patients with Severe Myocardial Infarction?.

Murad H, A Bakarman M Int J Angiol. 2023; 32(3):165-171.

PMID: 37576533 PMC: 10421681. DOI: 10.1055/s-0042-1756488.


PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.

Hsu F, Lin W, Kuo K, Chiu Y, Hsu C, Liao S Int J Mol Sci. 2021; 22(21).

PMID: 34769137 PMC: 8584183. DOI: 10.3390/ijms222111706.


A Role of CXCL1 Drives Osteosarcoma Lung Metastasis VCAM-1 Production.

Lee C, Chiang Y, Yu P, Peng K, Chi M, Lee M Front Oncol. 2021; 11:735277.

PMID: 34760697 PMC: 8573405. DOI: 10.3389/fonc.2021.735277.


CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.

Chao C, Lee W, Wang S, Chen P, Yamamoto A, Chang T J Cell Mol Med. 2021; 25(19):9128-9140.

PMID: 34427969 PMC: 8500967. DOI: 10.1111/jcmm.16743.


Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.

Sameri S, Mohammadi C, Mehrabani M, Najafi R BMC Complement Med Ther. 2021; 21(1):160.

PMID: 34059044 PMC: 8168007. DOI: 10.1186/s12906-021-03330-1.